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INTRODUCTION
HeLa Cells have been found to produce a pla-
cental form of alkaline phosphatase (1, 8, 17) which
is very similar to the Regan isoenzyme, a carcino-
placental antigen found in cancer patients (7-9).
In order to investigate the nature of gene expres-
sion of carcinoplacental proteins, HeLa cells were
cloned, and a subline (HeLa TCRC-1), mono-
phenotypic for the Regan isoenzyme was selected.
The properties of another line, HeLa TCRC-2
(HeLa 12-2), discovered by Kelly et al . (14) were
studied with regard to non-Regan isoenzyme.
MATERIALS AND METHODS
Culture Methods
Cells are maintained in monolayer cultures in
Eagle's minimum essential medium with Earle's salts,
modified for suspension culture' (Grand Island Bio-
logical Co., Grand Island, N.Y., catalog no. 165G),
' Cells have been adapted to grow in monolayer and
spinner culture, and are maintained on spinner cul-
ture media routinely. No gross difference in morphol-
ogy or growth has been noticeable due to prolonged
growth on low calcium media .
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10%), penicillin (100 U/ml), streptomycin (100
pg/ml), and Fungizone (2 .5 hg/ml). The medium
contains sodium bicarbonate at a final concentration
of 0. 1%.
Cultures are passaged weekly. Cell viability is
determined using trypan blue (16), and 200 X 103
viable cells are added to 30-ml Falcon tissue culture
bottles (Falcon Plastics, Div. B-D Laboratories, Inc.,
Los Angeles, Calif.) in 5-ml growth media . The
media is changed every other day. Cultures were
found to be negative for mycoplasma contamination
using a kit produced by Flow Laboratories, Inc.,
Rockville, Md.
Cells
The wild-type HeLa cells and HeLa TCRC-2
were kindly furnished by Dr. Robert Rustigian from
the Brockton V. A. Hospital, Brockton, Mass.
Cloning
Selection of HeLa cell clones for high levels of
Regan and non-Regan isoenzymes of alkaline phos-
phatase is accomplished using the method described
by Maio and DeCarli (15). Monodispersed suspen-
sions were plated out at very low density (100 cells
per 100-mm Petri dish). When colonies reached a
diameter of about 2 mm, a mixture of p-nitrophenyl
phosphate and agar at pH 9.4 was poured over the
plates. Colonies positive for alkaline phosphatase
appeared as brilliant yellow in 2=5 min . Approxi-
mately 6% of the colonies appeared positive . These
positive colonies were removed and placed in culture
until there were ample cell numbers to allow propaga-
tion of the cell lines.
The first property determined was heat stability.
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TABLE I
* Refers to reference number which describes method used .
ND, not determined .
83% of the colonies were heat stable at 65 °C for 5
min. The specific activities of these heat stable colonies
varied from 0.003 to 0.75 (smol/min/mg protein) .
HeLa TCRC-l was selected from this group on the
basis of high levels of heat-stable alkaline phosphatase
which is shown by this report to be Regan isoenzyme .
RESULTS
A summary of the properties of the two clones
TCRC-l and TCRC-2 appears in Table I .
The alkaline phosphatase of TCRC-1 has the
amino acid inhibition characteristics, 'heat stabil-
ity, and antigenic sites of placental alkaline phos-
phatase, whereas that of TCRC-2 possesses the
characteristics of non-Regan isoenzyme (6, 11, 13) .
As can be seen from Fig. 1 a, placental and
HeLa TCRC-I alkaline phosphatases form lines of
identity against antisera to placental alkaline phos-
phatase and no "spurs" are apparent . From Fig.
1 b in which the central well contains antisera to
HeLa TCRC-1, it can be seen that lines of identity
lacking spurs are formed between HeLa TCRC-1
and placental alkaline phosphatase, and no pre-
cipitin line is visible between rabbit antibody to
HeLa TCRC-I alkaline phosphatase and HeLa
TCRC-2. Thus, TCRC-1 produces alkaline phos-
phatase which is antigenically indistinguishable
from that of the placenta and can be referred to as
a Regan-producing cell line .
These HeLa cell lines respond differently to
prednisolone treatment (Table I) . Prednisolone
elevates alkaline phosphatase activity in HeLa
TCRC-1 after 24 h, and a maximum elevation
occurs on day 4. On the other hand, the hormone
exerts no significant effect for the first 6 days on
Some Characteristics of HeLa Clones
HeLa TCRC-1 HeLa TCRC-2 HeLa parent Ref.'
Alkaline phosphatase
In vitro
Specific activity (µmol/min/mg protein) 0 .75 3 .2 0 .09 6
L-Phenylalanine inhibition 73 .1 % 0 76 .5% 11
L-Homoarginine inhibition 11 .5% 77 .5% 36 .8% 10
Heat inactivation (5 min at 65 °C) 10 .9% 100% 5% 6
Reaction to placental antibody + - + 13
In culture
Prednisolone effect (24 h) on specific activity +175% 0% +500%
ß-Glucuronidase (µg phenolphthalein/h/mg) 32 5 .8 ND 4
Chromosome number 67-69 64 68-69 1FIGURE 1 a and b Ouchterlony double-diffusion plates . Plates are prepared as 1 .5 agarose (Seakem,
Marine Colloids) in 0.2 sodium barbitol buffer pH 8.6. Visualization of phosphohydrolase activity is by
the method of L. Fishman (3) . (a) Central well contains rabbit antisera to purified human placental alka-
line phosphatase (dilution 1 :50) . Wells 2 and 6 contain IIeLa TCRC-1 alkaline phosphatase. Wells 3 and
7 contain purified human placental alkaline pbosphatase. Wells 1, 4, 5, and 8 contain butanol extract of
HeLa TCRC-2. (b) Central well contains rabbit antisera to purified HeLa cell alkaline phosphatase (2) .
Wells 1 and 4 contain purified HeLa TCRC-1 alkaline phosphatase. Wells 2 and 5 contain unpurified
HeLa TCRC-1 alkaline phosphatase . Well 3 contains unpurified human placental alkaline phosphatase .
Well 6 contains purified human placental alkaline phosphatase.
the enzyme activity of HeLa TCRC-2 and there-
after suppresses the activity .
Base level and prednisolone-induced enzyme of
HeLa TCRC-l have been compared electro-
phoretically on a Beckman microzone cell (Beck-
man Instruments, Inc., Fullerton, Calif.) in the
presence and absence of antibody to placental
alkaline phosphatase as described by Inglis et al.
(13). Both the induced and the base level enzyme
migrate similarly on the cellulose acetate mem-
brane. They both fail to migrate in the presence
of the antibody to placental alkaline phosphatase.
Experiments indicate that in addition to the
aforementioned properties, these clones are quite
different with respect to 0-glucuronidase activity .
As seen in Table I, HeLa TCRC-1 has significant
levels of ß-glucuronidase activity while HeLa
TCRC-2 has low enzyme activity.
The chromosome number of HeLa TCRC-1,
the Regan line, ranges from 59 to 71, with most of
the population having between 67 and 69 chromo-
somes. There does not appear to be a clear modal
chromosome number. The chromosome number of
HeLa TCRC-2 ranges from 59 to 72 with a modal
chromosome number of 64 (Table I). The HeLa
parent strain is quite aneuploid, with a modal
chromosome number of 68 or 69. These karyotypes,
and the associated phenotypes show no signs of
instability thus far (6 mo).
DISCUSSION
The many HeLa variants which have been under
investigation should be mentioned. Thus, it has
been shown, for example, that HeLa S3 cells from
three different sources were very different with
respect to chromosome number and enzyme levels
(1) . HeLa A, HeLa 229, and HeLa55 undergo
glucocorticoid hormone induction (1, 12) . On the
other hand, it has also been reported that HeLa75,
HeLa71 (12), and HeLa G do not have elevated
alkaline phosphatase levels in the presence of
hydrocortisone (1) . What has been missing in these
other studies has been a thorough characterization
of the isoenzyme species.
With respect to chromosome number, neither of
our two cell lines has the karyotypic characteristics
of HeLa strains studied by Bottomley et al. (1) .
However, we have found, as they have, that
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seems to be related to chromosome number. Ex-
periments are now in progress to determine the
stability of chromosome number and phenotypic
expression of alkaline phosphatase.
With regard to the enrichment of TCRC-1 with
ß-glucuronidase, current studies are directed to
evaluating the significance of this finding in rela-
tion to expression of Regan isoenzyme and to its
well-known existence in neoplastic tissue (5, 18) .
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